Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real-time Neuromuscular Control of Exoskeletons

NCT: NCT04661891 · SUSPENDED

NCT IDNCT04661891
StatusSUSPENDED
Start Date2021-05-05
Completion2026-07-15
SponsorShirley Ryan AbilityLab (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to develop a real-time controller for exoskeletons using neural information embedded in human musculature. This controller will consist of an online interface that anticipates human movement based on high-density electromyography (HD-EMG) recordings, and then translates it into functional assistance. This study will be carried out in both healthy participants and participants post-stroke. The researchers will develop an online algorithm (decoder) in currently existing exoskeletons that can extract hundreds of motor unit (MU) spiking activity out of HD-EMG recordings. The MU spiking activity is a train of action potentials coded by its timing of occurrence that gives access to a representative part of the neural code of human movement. The researchers will also develop a command encoder that can anticipate human intent (multi-joint position and force commands) from MU spiking activity to translate the neural information to movement. The researchers will integrate the decoder with the command encoder to showcase the real-time control of multiple joint lower-limb exoskeletons.

Frequently Asked Questions

What is Real-time Neuromuscular Control of Exoskeletons?

Real-time Neuromuscular Control of Exoskeletons is a clinical trial registered under NCT04661891. Current status: SUSPENDED.

What is the status of NCT04661891?

The current status of NCT04661891 (Real-time Neuromuscular Control of Exoskeletons) is: SUSPENDED.

When did Real-time Neuromuscular Control of Exoskeletons start?

Real-time Neuromuscular Control of Exoskeletons started on 2021-05-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.